1-3 of 3
Apurva Srivastava
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 393: Determinants of birinapant efficacy in triple negative breast cancer

Free
Elisabeth A. Brown, Chieh-Hsiang Yang, Emilio Cortes-Sanchez, Zhengtao Chu, Jeevan Govindharajulu, Ralph Parchment, James Doroshow, Apurva Srivastava, Alana Welm
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 393.
https://doi.org/10.1158/1538-7445.AM2023-393
Published: 04 April 2023
View articletitled, Abstract 393: Determinants of birinapant efficacy in triple negative breast cancer
Journal Articles

Abstract CT138: Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors, lymphomas, or myelodysplastic syndromes

Free
James Q. Nguyen, Geraldine O'Sullivan Coyne, Larry Rubinstein, Shivaani Kummar, Lamin Juwara, Jennifer Zlott, Abdul Rafeh Naqash, Murielle Hogu, Jerry Collins, Apurva Srivastava, Brandon Miller, Ralph E. Parchment, Robert Meehan, Christopher S. Hourigan, Steven Pavletic, James H. Doroshow, Alice P. Chen, Naoko Takebe
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT138.
https://doi.org/10.1158/1538-7445.AM2021-CT138
Published: 01 July 2021
View articletitled, Abstract CT138: Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors, lymphomas, or myelodysplastic syndromes
Journal Articles

The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

Available to Purchase
Susan L. Holbeck, Richard Camalier, James A. Crowell, Jeevan Prasaad Govindharajulu, Melinda Hollingshead, Lawrence W. Anderson, Eric Polley, Larry Rubinstein, Apurva Srivastava, Deborah Wilsker, Jerry M. Collins, James H. Doroshow
Journal: Cancer Research
Cancer Res (2017) 77 (13): 3564–3576.
https://doi.org/10.1158/0008-5472.CAN-17-0489
Published: 01 July 2017
View articletitled, The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity
Open the PDF for The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity in another window
Includes: Supplementary data